Last deal

$35M

Amount

Series A

Stage

19.07.2024

Date

2

all rounds

$68M

Total amount

General

About Company
Rona Therapeutics is a company that develops a platform for RNA medicine discovery.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2021

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

Rona Therapeutics is focused on creating innovative and disruptive RNA medicines using their proprietary platform. They are building advanced facilities to expand their capabilities in nucleic acid synthesis, delivery platform, oligonucleotide chemical modification, RNA biology, and manufacturing. Their goal is to develop modular and programmable RNA medicines to treat various diseases, including metabolic diseases, neurological diseases, and ophthalmology diseases. Rona Therapeutics offers a fully integrated RNA therapeutic platform for the discovery, development, and manufacturing of RNA therapeutics.
Contacts